141
Participants
Start Date
January 22, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
May 31, 2026
DBS TaT
Dried Blood Spot (DBS) testing for HCV DCHEQ and Baseline Surveys If at high risk for liver fibrosis, blood draw prior to treatment initiation If low risk for liver fibrosis, Telemedicine visit with PATHS provider HCV treatment initiation Transient elastography (TEG)
Usual Care
Point-of-care or DBS testing for HCV Blood draw to test liver fibrosis DCHEQ and Baseline Surveys Telemedicine visit with PATHS provider HCV treatment initiation Transient elastography (TEG)
RECRUITING
Oregon Health & Science University, Portland
National Center for Advancing Translational Sciences (NCATS)
NIH
Oregon Clinical and Translational Research Institute
OTHER
Collins Medical Trust
OTHER
Oregon Health and Science University
OTHER